long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 19:06 (320 d 04:36 ago) – Posting: # 21342
Views: 788


» But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.

Have you found out why the increase in half-life?


Complete thread:

 Admin contact
21,371 posts in 4,463 threads, 1,496 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Sunday 23:42 UTC (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz